Epidemiology of anaphylaxis - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Current Opinion in Allergy and Clinical Immunology Année : 2021

Epidemiology of anaphylaxis

Résumé

Anaphylaxis is a complex noncommunicable diseases with adverse impact on health-related quality of life of patients and their carriers and a significant proportion of deaths may be preventable. It requires an integrated holistic plan to improve quality of healthcare and gathering accurate and comparable epidemiological data is key. Morbidity related to anaphylaxis seems to be increasing worldwide whereas mortality of anaphylaxis appears to be low and stable, but this still has great challenges in capturing quality anaphylaxis MMS. Improving the quality of epidemiological data related to anaphylaxis should clarify some areas of uncertainty about risk factors, leading to better targeting of strategies to protect those patients at risk. As knowledge derived from populations is key information for more realistic decision-making, the construction of the new section addressed to anaphylaxis in the ICD-11 will allow the collection of more accurate epidemiological data to support quality management of patients, and better facilitate healthcare planning to implement public health measures to prevent and reduce the morbidity and mortality attributable to these conditions.
Fichier non déposé

Dates et versions

hal-03647147 , version 1 (20-04-2022)

Identifiants

Citer

Luciana Kase Tanno, Pascal Demoly. Epidemiology of anaphylaxis. Current Opinion in Allergy and Clinical Immunology, 2021, 21 (2), pp.168-174. ⟨10.1097/ACI.0000000000000722⟩. ⟨hal-03647147⟩
21 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More